Follow
Kaat de Jonge
Kaat de Jonge
Center for experimental therapies, Department of Oncology, University hospital of Lausanne
Verified email at chuv.ch
Title
Cited by
Cited by
Year
Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data
J Racle, K de Jonge, P Baumgaertner, DE Speiser, D Gfeller
elife 6, e26476, 2017
9252017
Circulating CD56bright NK cells inversely correlate with survival of melanoma patients
K de Jonge, A Ebering, S Nassiri, H Maby-El Hajjami, ...
Scientific reports 9 (1), 4487, 2019
632019
Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma
N Bordry, MAS Broggi, K de Jonge, K Schaeuble, PO Gannon, PG Foukas, ...
Oncoimmunology 7 (8), e1462878, 2018
562018
Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patients
K de Jonge, L Tillé, J Lourenco, H Maby-El Hajjami, S Nassiri, J Racle, ...
Oncoimmunology 10 (1), 1873585, 2021
182021
STAT6 Mediates Footpad Immunopathology in the Absence of IL-12p40 Following Infection of Susceptible BALB/c Mice With Leishmania major
F Kauffmann, E Meert, K De Jonge, Y Elkrim, D Hanot Mambres, O Denis, ...
Frontiers in immunology 9, 503, 2018
82018
A Personalized neoantigen vaccine in combination with platinum-based chemotherapy induces a T-Cell response coinciding with a complete response in endometrial carcinoma
A Harari, A Sarivalasis, K de Jonge, AC Thierry, F Huber, C Boudousquie, ...
Cancers 13 (22), 5801, 2021
42021
Author response: Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data
J Racle, K de Jonge, P Baumgaertner, DE Speiser, D Gfeller
The system can't perform the operation now. Try again later.
Articles 1–7